209 related articles for article (PubMed ID: 31795827)
1. Hyperthermia and immunotherapy: clinical opportunities.
Hurwitz MD
Int J Hyperthermia; 2019 Nov; 36(sup1):4-9. PubMed ID: 31795827
[TBL] [Abstract][Full Text] [Related]
2. Local tumour hyperthermia as immunotherapy for metastatic cancer.
Toraya-Brown S; Fiering S
Int J Hyperthermia; 2014 Dec; 30(8):531-9. PubMed ID: 25430985
[TBL] [Abstract][Full Text] [Related]
3. Hyperthermia, radiation and chemotherapy: the role of heat in multidisciplinary cancer care.
Hurwitz M; Stauffer P
Semin Oncol; 2014 Dec; 41(6):714-29. PubMed ID: 25499632
[TBL] [Abstract][Full Text] [Related]
4. Combinatorial immunotherapy and nanoparticle mediated hyperthermia.
Moy AJ; Tunnell JW
Adv Drug Deliv Rev; 2017 May; 114():175-183. PubMed ID: 28625829
[TBL] [Abstract][Full Text] [Related]
5. Targeted near infrared hyperthermia combined with immune stimulation for optimized therapeutic efficacy in thyroid cancer treatment.
Zhou L; Zhang M; Fu Q; Li J; Sun H
Oncotarget; 2016 Feb; 7(6):6878-90. PubMed ID: 26769848
[TBL] [Abstract][Full Text] [Related]
6. Immune biological rationales for the design of combined radio- and immunotherapies.
Hader M; Frey B; Fietkau R; Hecht M; Gaipl US
Cancer Immunol Immunother; 2020 Feb; 69(2):293-306. PubMed ID: 31953578
[TBL] [Abstract][Full Text] [Related]
7. The Role of Hyperthermia in the Multidisciplinary Treatment of Malignant Tumors.
Cheng Y; Weng S; Yu L; Zhu N; Yang M; Yuan Y
Integr Cancer Ther; 2019; 18():1534735419876345. PubMed ID: 31522574
[TBL] [Abstract][Full Text] [Related]
8. [Principles, technology and indication of hyperthermia and part body hyperthermia].
Schlemmer M; Lindner LH; Abdel-Rahman S; Issels RD
Radiologe; 2004 Apr; 44(4):301-9. PubMed ID: 15042293
[TBL] [Abstract][Full Text] [Related]
9. Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy.
Lee S; Son B; Park G; Kim H; Kang H; Jeon J; Youn H; Youn B
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227629
[TBL] [Abstract][Full Text] [Related]
10. Recent Progress in the Synergistic Combination of Nanoparticle-Mediated Hyperthermia and Immunotherapy for Treatment of Cancer.
Stephen ZR; Zhang M
Adv Healthc Mater; 2021 Jan; 10(2):e2001415. PubMed ID: 33236511
[TBL] [Abstract][Full Text] [Related]
11. Hyperthermia for rectal cancer.
Ohno S; Sumiyoshi Y; Mori M; Sugimachi K
Surgery; 2002 Jan; 131(1 Suppl):S121-7. PubMed ID: 11821798
[TBL] [Abstract][Full Text] [Related]
12. Heating the patient: a promising approach?
van der Zee J
Ann Oncol; 2002 Aug; 13(8):1173-84. PubMed ID: 12181239
[TBL] [Abstract][Full Text] [Related]
13. Harnessing Hyperthermia: Molecular, Cellular, and Immunological Insights for Enhanced Anticancer Therapies.
Lukácsi S; Munkácsy G; Győrffy B
Integr Cancer Ther; 2024; 23():15347354241242094. PubMed ID: 38818970
[TBL] [Abstract][Full Text] [Related]
14. Heat immunotherapy using magnetic nanoparticles and dendritic cells for T-lymphoma.
Tanaka K; Ito A; Kobayashi T; Kawamura T; Shimada S; Matsumoto K; Saida T; Honda H
J Biosci Bioeng; 2005 Jul; 100(1):112-5. PubMed ID: 16233860
[TBL] [Abstract][Full Text] [Related]
15. Effects of hyperthermia and irradiation on the growth of mouse melanoma tumors following immunotherapy.
Green DM; Samulski TV; Vervaert C; Halperin EC; Oleson JR; Seigler H
J Surg Oncol; 1990 Aug; 44(4):256-9. PubMed ID: 2385103
[TBL] [Abstract][Full Text] [Related]
16. Radiant heat systemic hyperthermia clinical trials.
Robins HI; Cohen JD
Adv Exp Med Biol; 1990; 267():189-96. PubMed ID: 2088034
[TBL] [Abstract][Full Text] [Related]
17. Whole body hyperthermia in the treatment of neoplastic disease.
Robins HI; Hugander A; Cohen JD
Radiol Clin North Am; 1989 May; 27(3):603-10. PubMed ID: 2648462
[TBL] [Abstract][Full Text] [Related]
18. Emerging hyperthermia applications for pediatric oncology.
Tydings C; Sharma KV; Kim A; Yarmolenko PS
Adv Drug Deliv Rev; 2020; 163-164():157-167. PubMed ID: 33203538
[TBL] [Abstract][Full Text] [Related]
19. Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics?
Datta NR; Krishnan S; Speiser DE; Neufeld E; Kuster N; Bodis S; Hofmann H
Cancer Treat Rev; 2016 Nov; 50():217-227. PubMed ID: 27756009
[TBL] [Abstract][Full Text] [Related]
20. Preferential radiosensitization of human prostatic carcinoma cells by mild hyperthermia.
Ryu S; Brown SL; Kim SH; Khil MS; Kim JH
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):133-8. PubMed ID: 12118542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
